Company profile
| Trading name | NARD Institute, Ltd. | 
|---|---|
| Locations | Headquarters: 2-6-1 Nishinagasu-cho, Amagasaki City, Hyogo Prefecture 660-0805, Japan TEL.+81-6-6482-7010 FAX.+81-6-6482-8020 | 
| Kobe Research Laboratory: 5-4-1 Minatojima Minamimachi, Chuo-ku, Kobe City, Hyogo Prefecture 650-004, Japan +81-78-958-7011 FAX.+81-78-958-8021 | |
| Executives | Yukio Dohi, President and CEO | 
| Akihiko Kawasaki, Chief Operating Officer | |
| Isao Hirota, Director Yuzo Ogawa, Director | |
| Mitsuhiro Asakura, Executive Officer Shin Gohda, Executive Officer Toshiki Nishino, Executive Officer | |
| Hirohisa Otsuka, Auditor Masaichi Nomura, Auditor (licensed certified public accountant) | |
| Senior Advisor | Teruhiro Arakawa | 
| Establishment | March 14, 1972 | 
| Capital investment | 100,000,000 JPY | 
| Employees | 154 (Including the number of employees of Nard Chemicals, LTD.) (as of April, 2024) | 
| Technical Advisers | Hiroshi Akimoto, PhD (pharmacology). Formerly, executive managing director, Takeda Pharmaceutical Co., Ltd. | 
| Group company | About NARD Chemicals | 
Corporate History
| 1972 | 
 | 
|---|---|
| 
 | |
| 1975 | 
 | 
| 1987 | 
 | 
| 1989 | 
 | 
| 1995 | 
 | 
| 1997 | 
 | 
| 1998 | 
 | 
| 1999 | 
 | 
| 2000 | 
 | 
| 2007 | 
 | 
| 
 | |
| 2012 | 
 | 
| 2014 | 
 | 
| 2018 | 
 | 
| 2022 | 
 | 
Patent applications as of the end of December 2023: 202 (Refer to J-PlatPat for details)
Revenue: 4,300,000,000 JPY (FY 2023)




